Literature DB >> 3931502

Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men.

J M Dony, A G Smals, R Rolland, B C Fauser, C M Thomas.   

Abstract

Administration of the antiestrogen tamoxifen for one month to 12 patients with idiopathic oligozoospermia significantly increased the mean basal testosterone (T) level and the responses of luteinizing hormone (LH) and follicle stimulating hormone (FSH) to constant luteinizing hormone releasing hormone (LHRH) infusion but did not significantly influence the mean oestradiol (E2) levels or the E2 over testosterone ratio. Mean sperm concentration and total sperm output increased by about 70% after a mean treatment period of 5.5 +/- 0.4 months. No statistically significant difference was found between the two subgroups of patients treated with either the lower (5 or 10 mg once daily) or higher dose of tamoxifen (10 mg twice daily) with respect to basal or LHRH stimulated gonadotropin and testosterone response or the E2/T ratio and the effect on sperm density and total sperm output. In both subgroups the sperm motility and morphology remained unchanged. In conclusion higher doses of tamoxifen in this study prove not to be superior to lower doses in improving mean sperm density and total sperm output. The relative small percentage of patients achieving normalisation of only these sperm parameters pleads for further search for more effective selection of patients and other more effective treatment modalities in patients with idiopathic oligozoospermia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931502     DOI: 10.1111/j.1439-0272.1985.tb01024.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  5 in total

Review 1.  Anti-estrogens and aromatase inhibitors: tamoxifen and testolactone.

Authors:  F Sciarra
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

Review 2.  Oestrogens and spermatogenesis.

Authors:  Serge Carreau; Rex A Hess
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

Review 3.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

4.  Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal.

Authors:  Teoman Cem Kadioglu
Journal:  Int Urol Nephrol       Date:  2009-04-21       Impact factor: 2.370

Review 5.  Estrogens as antioxidant modulators in human fertility.

Authors:  A Mancini; S Raimondo; M Persano; C Di Segni; M Cammarano; G Gadotti; A Silvestrini; A Pontecorvi; E Meucci
Journal:  Int J Endocrinol       Date:  2013-11-20       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.